Proceedings of the 43rd Annual General Meting

30th September, 2026 Corporate Relationship Department The Manager - Listing M/s. BSE Limited M/s. National Stock Exchange of India Ltd Dalal Street, Fort “Exchange Plaza”, Bandra – Kurla Complex Mumbai 400 001. Bandra (E) Mumbai 400 051. Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir/ Madam, Sub: Proceedings of the 43rd Annual General Meeting In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time, please find enclosed herewith the proceedings of the 43rd Annual General Meeting held on today i.e., 30th September, 2026. The Video Proceedings of the 43rd Annual General Meeting will be made available on the website of the Company. This is for your information and records. Thanking you, Yours Faithfully, For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer Encl: a.a. PROCEEDINGS OF THE 43RD ANNUAL GENERAL MEETING OF THE COMPANY HELD ON WEDNESDAY, THE 30TH DAY OF SEPTEMBER, 2026 AT 11.00 A.M. AT THE REGISTERED OFFICE AT NATCO HOUSE, ROAD NO.2, BANJARA HILLS, HYDERABAD 500 034, TELANGANA, INDIA THROUGH VIDEO CONFERENCE Directors personally present at the registered office 1. Sri V.C. Nannapaneni Chairman and Managing Director, Chairman of the Risk Management Committee and Corporate Social Responsibility Committee 2. Sri Rajeev Nannapaneni Vice Chairman & CEO Directors present through video conference from their respective places 3. Sri P.S.R.K. Prasad Director & Executive Vice President (Corporate Engineering Services) 4. Dr. D. Linga Rao Director & President (Technical Affairs) 5. Sri D. Vijaya Bhaskar Independent Director and Chairman of Nomination and Remuneration Committee and Stakeholders Relationship Committee 6. Sri A.D.M. Chavali Independent Director 7. Sri B. Lakshminarayana Independent Director and Chairman of Audit Committee 8. Dr. K. Suma Independent Director 9. Sri Nitin Jain Independent Director Company Secretary CS Ch. Venkat Ramesh, Company Secretary & Compliance Officer Others Present i. CA Amit Parekh, Chief Financial Officer ii. CA Ankit Jalan, Director of M/s. B S R and Co, Statutory Auditors iii. CS B Kiran Kumar, Proprietor, M/s. BK & Associates, Practicing Company Secretary, Secretarial Auditors and Scrutinizer for the e-voting process A total of 51 members were present during the Annual General Meeting (AGM) through Video Conference and e-voting facility. The Company Secretary of the Company welcomed all the Members and Directors of the Company who were present at the AGM through Video Conference. Sri V.C. Nannapaneni, Chairman & Managing Director of the Company, occupied the Chair, conducted the proceedings of the meeting and informed that the requisite quorum was present to commence the proceedings: • Chairman requested Sri Rajeev Nannapaneni, Vice Chairman & Chief Executive Officer, to read out the Chairman’s Speech. Accordingly, Vice Chairman & Chief Executive Officer presented the Chairman’s Speech to the Members. • The Chairman informed that with the permission of the Members the notice convening the meeting, Board’s Report and other reports were taken as read. The report of Statutory Auditors is unqualified and without any adverse observations or comments in their report and the same was taken as read. • The Chairman informed the members that the Company has provided remote e-voting facility to the Members from 27th September, 2026 (9.00 a.m.) to 29th September, 2026 (5.00 p.m.) in order to exercise their right to vote for the items of business of 43rd AGM. Members who have not availed the remote e-voting facility, for those members e-voting during the AGM has been provided. • The following items of business were considered at the AGM: ORDINARY BUSINESS: 1 Adoption of audited Annual Financial Statements for the Financial Year 2025-26 2 To confirm three interim dividends aggregating to ₹5.00 per share paid on equity shares during the Financial Year 2025-26 as dividend for the FY 2025-26 3 Re-appointment of Sri P.S.R.K. Prasad (DIN: 07011140) as a Director liable to retire by rotation SPECIAL BUSINESS: 4 Ratification of remuneration of Cost Auditors 5 To approve raising of funds in one or more tranches, by issuance of securities by way of preferential issue, rights issue, private placement (including qualified institutions placement(s)) and/or any combination thereof or any other method as may be permitted under applicable law for an amount not exceeding ₹2,000 crores • Chairman instructed the moderator for the VC to enable the Speaker shareholders to raise the comments/queries with regard to the reports and accounts. Vice-Chairman & CEO and Chief Financial Officer appropriately answered the queries raised by the members. • The Chairman then informed that the combined results on the remote e-voting and e-voting during the AGM would be announced within two working days of conclusion of the AGM. • The Company Secretary of the Company thanked the Members for their active participation in the AGM and declared that the business for which the AGM is convened is completed. The meeting was concluded at 11.29 a.m. Thanking you, Yours Faithfully, For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer